Oculis Holding AG
OCSAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.
Other share classesOCS
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $1.16M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OCSAW, Q2 2026
No superinvestor reported holding OCSAW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Oculis Holding AG insiders from Form 4, newest first.
No open-market purchases or sales by Oculis Holding AG insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Oculis Holding AG at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 73,025 | $365.1K | 0.03% | 00.0% | Unchanged |
| Jane Street Group, LLC | 45,702 | $228.5K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 39,949 | $199.7K | 0.00% | +39,949 | New |
| D. E. Shaw & Co., Inc. | 34,716 | $173.6K | 0.00% | 00.0% | Unchanged |
| Moore Capital Management, LP | 20,000 | $100.0K | 0.00% | −21,666−52.0% | Reduced |
| Vestcor Inc | 11,666 | $58.0K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 5,833 | $29.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 300 | $1.50K | 0.00% | +30+11.1% | Added |